Pasithea Therapeutics Corp. Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KTTAW and buy or sell other stocks, ETFs, and their options commission-free!About KTTAW
Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J.
CEOTiago Reis Marques, MD, PhD
CEOTiago Reis Marques, MD, PhD
Employees—
Employees—
HeadquartersMiami Beach, Florida
HeadquartersMiami Beach, Florida
Founded2020
Founded2020
Employees—
Employees—
KTTAW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume207.97K
Average volume207.97K
High today$0.0437
High today$0.0437
Low today$0.0364
Low today$0.0364
Open price$0.0436
Open price$0.0436
Volume9.56K
Volume9.56K
52 Week high$0.1198
52 Week high$0.1198
52 Week low$0.0108
52 Week low$0.0108
Stock Snapshot
Pasithea Therapeutics Corp. Warrant(KTTAW) trades at $0.04.
On 2025-12-09, Pasithea Therapeutics Corp. Warrant(KTTAW) stock moved within a range of $0.04 to $0.04. With shares now at $0.04, the stock is trading +19.5% above its intraday low and -0.5% below the session's peak.
Trading activity shows a volume of 9.56K, compared to an average daily volume of 207.97K.
Over the past 52 weeks, Pasithea Therapeutics Corp. Warrant(KTTAW) stock has traded between a high of $0.12 and a low of $0.01.
Over the past 52 weeks, Pasithea Therapeutics Corp. Warrant(KTTAW) stock has traded between a high of $0.12 and a low of $0.01.